A comprehensive view of Cedars-Sinai. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

COVID-19 vaccination appears to strengthened T-cell immune response in inflammatory bowel disease patients taking anti-tumor necrosis factor drug therapy; association reported between biologic drugs, reduced hospitalizations, deaths from COVID-19: study

CDC reports 80% of babies hospitalized with COVID-19 are born to unvaccinated women, while nearly 60% of newborns from vaccinated mothers protected from illness; 62% of pregnant women in US have received at least one dose of vaccine: Cedars-Sinai

Cedars-Sinai develops potential COVID-19 biological therapy using reengineered human skin cells; dermal fibroblasts called ASTEX inhibit viral replication in human lung cells, protect infected cells, repair heart, lung, muscle tissue in laboratory mice

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count